Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

MLA

Purev Enkhtsetseg, et al. “Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes.” Blood, vol. 128, Dec. 2016, p. 3054. EBSCOhost, https://doi.org/10.1182/blood.v128.22.3054.3054.

APA

Purev Enkhtsetseg, Bradley M. Haverkos, William A. Robinson, Jeffrey Schowinsky, Clayton A. Smith, Daniel W. Sherbenou, Weitzenkamp David, Daniel A. Pollyea, Craig T. Jordan, Douglas E. Ney, Lilyana Gross, Jonathan A. Gutman, Zohra Nooruddin, Zenggang Pan, Manali Kamdar, & Rachel Rabinovitch. (2016). Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes. Blood, 128, 3054. https://doi.org/10.1182/blood.v128.22.3054.3054

Chicago

Purev Enkhtsetseg, Bradley M. Haverkos, William A. Robinson, Jeffrey Schowinsky, Clayton A. Smith, Daniel W. Sherbenou, Weitzenkamp David, et al. 2016. “Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes.” Blood 128 (December): 3054. doi:10.1182/blood.v128.22.3054.3054.